Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAML
Status:
Recruiting
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This research is being done to assess the therapeutic efficacy and safety of a promising
regimen (Venetoclax combined with Azacitidine and Harringtonine) in patients with secondary
AML
This study involves the following:
Venetoclax combined with Azacitidine and Harringtonine
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University